MicroPort NeuroTech Limited
MicroPort NeuroTech Limited Fundamental Analysis
MicroPort NeuroTech Limited (2172.HK) shows moderate financial fundamentals with a PE ratio of 29.68, profit margin of 23.35%, and ROE of 10.38%. The company generates $0.8B in annual revenue with weak year-over-year growth of 1.08%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 56.8/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze 2172.HK's fundamental strength across five key dimensions:
Efficiency Score
Weak2172.HK struggles to generate sufficient returns from assets.
Valuation Score
Moderate2172.HK shows balanced valuation metrics.
Growth Score
Weak2172.HK faces weak or negative growth trends.
Financial Health Score
Excellent2172.HK maintains a strong and stable balance sheet.
Profitability Score
Moderate2172.HK maintains healthy but balanced margins.
Key Financial Metrics
Is 2172.HK Expensive or Cheap?
P/E Ratio
2172.HK trades at 29.68 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, 2172.HK's PEG of -3.94 indicates potential undervaluation.
Price to Book
The market values MicroPort NeuroTech Limited at 3.02 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 17.92 times EBITDA. This signals the market has high growth expectations.
How Well Does 2172.HK Make Money?
Net Profit Margin
For every $100 in sales, MicroPort NeuroTech Limited keeps $23.35 as profit after all expenses.
Operating Margin
Core operations generate 37.67 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $10.38 in profit for every $100 of shareholder equity.
ROA
MicroPort NeuroTech Limited generates $8.68 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
MicroPort NeuroTech Limited produces operating cash flow of $184.23M, showing steady but balanced cash generation.
Free Cash Flow
MicroPort NeuroTech Limited generates strong free cash flow of $179.16M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.31 in free cash annually.
FCF Yield
2172.HK converts 3.26% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
29.68
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-3.94
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.02
vs 25 benchmark
P/S Ratio
Price to sales ratio
6.98
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.009
vs 25 benchmark
Current Ratio
Current assets to current liabilities
6.008
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.10
vs 25 benchmark
ROA
Return on assets percentage
0.09
vs 25 benchmark
ROCE
Return on capital employed
0.16
vs 25 benchmark
How 2172.HK Stacks Against Its Sector Peers
| Metric | 2172.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 29.68 | 28.54 | Neutral |
| ROE | 10.38% | 738.00% | Weak |
| Net Margin | 23.35% | -43982.00% (disorted) | Strong |
| Debt/Equity | 0.01 | 0.34 | Strong (Low Leverage) |
| Current Ratio | 6.01 | 2806.01 | Strong Liquidity |
| ROA | 8.68% | -14624.00% (disorted) | Weak |
2172.HK outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews MicroPort NeuroTech Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
254.34%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
305.30%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
-100.00%
Industry Style: Defensive, Growth, Innovation
Declining